Overview

Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain

Status:
Unknown status
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
- History of clinical breast pain for at least the last six months. - At least six days of moderate or severe breast pain per cycle. - Fibrosis, cysts, nodules involving at least 25% of the surface of one breast. - Euthyroid with no prior history of thyroid disease. - Six months of daily therapy with molecular iodine. - Placebo controlled vs active (1:1).
Phase:
Phase 3
Details
Lead Sponsor:
Symbollon Pharmaceuticals
Treatments:
Cadexomer iodine
Iodine